Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation

1. Peris, I.
2. Romero-Murillo, S.
3. Martínez-Balsalobre, E.
4. Farrington, C.C.
5. Arriazu, E.
6. Marcotegui, N.
7. Jiménez-Muñoz, M.
8. Alburquerque-Prieto, C.
9. Torres-López, A.
10. Fresquet, V.
11. Martínez-Climent, J.A.
12. Mateos, M.C.
13. Cayuela, M.L.
14. Narla, G.
15. Odero, M.D.
16. Vicente, C.